Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)
CAPS Rating:
A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.
RSS Headlines
Fool UK
Recs
Drug for opioid-induced constipation has had very good trial results. FDA submission next year. Also discovered receptor HIV uses to enter cells, a potential blockbuster drug target, but still pretty far off.